Bio-Standards

Bio-Standards company information, Employees & Contact Information

Explore related pages

Related company profiles:

About us: Bio-Standards was established in 2010 as a regulatory representative consultants specializing in Medical Device registration with the Saudi Food & Drug Authority (SFDA) and local markets access for international manufacturers of Medical Devices and Pharmaceuticals. Our team members understand SFDA regulations in detail and are skilled in overcoming difficult challenges and providing our clients with the best compliance & logistic strategy. This approach enables us to create comprehensive solutions for all relevant parties to gain smooth access to the Saudi market and surrounding countries. Bio-Standards handle all the sensitive tasks to their maximum intensities with professional integrity, accuracy, and transparency. Mission: To facilitate the access of International manufacturers to the Saudi Market and surrounding countries by meeting specific local regulations and requirements with integrity and perfection. Vision: To be the leading consulting firm and regulatory affairs expert in the Kingdom of Saudi Arabia & GCC countries.

Company Details

Employees
45
Founded
-
Address
Al Imam Abdullah Ibn Saud Ibn Abdulaziz Branch Road - Al Shohda Dist., Baghlaf Corner Center,saudi Arabia
Industry
Business Consulting And Services
NAICS
Management, Scientific, and Technical Consulting Services
Management Consulting Services
Other Scientific and Technical Consulting Services
Other Management Consulting Services
HQ
riyadh, riyadh
Looking for a particular Bio-Standards employee's phone or email?

Bio-Standards Questions

News

Novartis nears deal to acquire Avidity Biosciences for over $70 per share - Business Standard

Novartis nears deal to acquire Avidity Biosciences for over $70 per share Business Standard

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development - PR Newswire

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development PR Newswire

Bio-Techne Partners With USP To Distribute MAb And AAV Standards For Biotherapeutic Development - Nasdaq

Bio-Techne Partners With USP To Distribute MAb And AAV Standards For Biotherapeutic Development Nasdaq

Setting standards to promote progress in bio–nano science - Nature

Setting standards to promote progress in bio–nano science Nature

San Pablo EDC hosting bio-tech hiring fair on Wednesday - Richmond Standard

San Pablo EDC hosting bio-tech hiring fair on Wednesday Richmond Standard

Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr - Business Standard

Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr Business Standard

ACS Synthetic Biology Adopts SBOL Synthetic Biology Standards - SynBioBeta

ACS Synthetic Biology Adopts SBOL Synthetic Biology Standards SynBioBeta

Protoblock - A biological standard for formalin fixed samples - BioMed Central

Protoblock - A biological standard for formalin fixed samples BioMed Central

Anthropic's Responsible Scaling Policy - Anthropic

Anthropic's Responsible Scaling Policy Anthropic

Spectrum Health Innovations partners with Min-Bio in Lowell - Sentinel-Standard

Spectrum Health Innovations partners with Min-Bio in Lowell Sentinel-Standard

Six factors affecting reproducibility in life science research and how to handle them - Nature

Six factors affecting reproducibility in life science research and how to handle them Nature

Suven Pharma to acquire majority stake in US-based NJ Bio - Business Standard

Suven Pharma to acquire majority stake in US-based NJ Bio Business Standard

LT Foods acquires 17.5% stake in Nature Bio-Foods - Business Standard

LT Foods acquires 17.5% stake in Nature Bio-Foods Business Standard

Piramal Pharma invests Rs 101.77 cr for minority stake in Yapan Bio - Business Standard

Piramal Pharma invests Rs 101.77 cr for minority stake in Yapan Bio Business Standard

Bio-E3 policy to usher in bio-revolution in India: Jitendra Singh - Business Standard

Bio-E3 policy to usher in bio-revolution in India: Jitendra Singh Business Standard

We re-do all clinical studies, says GVK Bio - Business Standard

We re-do all clinical studies, says GVK Bio Business Standard

Avery Dennison launches bio-based PE film for label applications - Business Standard

Avery Dennison launches bio-based PE film for label applications Business Standard

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant